History
  • No items yet
midpage
SmartGene, Inc. v. Advanced Biological Laboratories, SA
555 F. App'x 950
Fed. Cir.
2014
Read the full case

Background

  • SmartGene sued ABL seeking declaratory judgment that U.S. Patents Nos. 6,081,786 and 6,188,988 (claims reciting a method, system, and computer program to guide selection of therapeutic regimens) are ineligible under 35 U.S.C. § 101; ABL counterclaimed for infringement of claims 1 and 23 of both patents.
  • Representative claim (claim 1 of the ’786 patent) recites: provide patient information to a computing device with knowledge bases and expert rules; generate a ranked listing of treatment regimens; generate advisory information based on patient data and rules.
  • SmartGene moved for summary judgment that all claims of both patents are § 101–ineligible, expressly treating claim 1 as representative; ABL did not contest that characterization in its briefing (but argued at oral argument that system claims differ).
  • District court analyzed claim 1 as representative, found it claimed an abstract mental process implemented on a generic computer, and held all claims invalid under § 101; reconsideration was denied.
  • On appeal, the Federal Circuit affirmed: (1) the district court properly adjudicated all claims based on SmartGene’s filings and ABL’s failure to develop a contrary argument; and (2) claim 1 is directed to an ineligible mental process implemented on generic computer components.

Issues

Issue SmartGene's Argument ABL's Argument Held
Whether the district court could resolve eligibility of all claims based on claim 1 as representative All claims were properly put at issue; claim 1 is representative and differences are immaterial System and method claims may require different analysis; other claims should not be treated the same as claim 1 Affirmed: district court properly adjudicated all claims; ABL forfeited any developed argument to treat claims differently because it did not contest representativeness in briefing
Whether claim 1 is patent-eligible under 35 U.S.C. § 101 The claim is facially invalid as it claims an abstract mental process implemented on a generic computer The claim recites a computer/system and thus is not abstract (system claims differ) Affirmed: claim 1 is directed to an abstract mental process (routine comparing and rule application) implemented on generic computer functionality and is therefore ineligible under § 101

Key Cases Cited

  • CyberSource Corp. v. Retail Decisions, Inc., 654 F.3d 1366 (Fed. Cir. 2011) (software-implemented mental-step claims invalid under § 101)
  • Gottschalk v. Benson, 409 U.S. 63 (1972) (abstract ideas and mental processes not patentable)
  • Parker v. Flook, 437 U.S. 584 (1978) (process claims that merely implement abstract formulas are ineligible)
  • Mayo Collaborative Servs. v. Prometheus Labs., Inc., 132 S. Ct. 1289 (2012) (claims involving laws of nature, abstract ideas, or mental processes require additional inventive concept beyond routine, conventional activity)
  • Bancorp Servs., LLC v. Sun Life Assurance Co. of Canada, 687 F.3d 1266 (Fed. Cir. 2012) (process claims using generic computer functions held ineligible)
  • CLS Bank Int'l v. Alice Corp. Pty, 717 F.3d 1269 (Fed. Cir. 2013) (en banc) (analysis of abstract ideas and computer implementation in patent eligibility)
  • In re Grams, 888 F.2d 835 (Fed. Cir. 1989) (mental processes not patentable)
  • In re Meyer, 688 F.2d 789 (C.C.P.A. 1982) (claims to mental processes ineligible)
Read the full case

Case Details

Case Name: SmartGene, Inc. v. Advanced Biological Laboratories, SA
Court Name: Court of Appeals for the Federal Circuit
Date Published: Jan 24, 2014
Citation: 555 F. App'x 950
Docket Number: 2013-1186
Court Abbreviation: Fed. Cir.